Cognitive and Psychological Impact of BRCA Genetic Counseling in Before and After Definitive Surgery Breast Cancer Patients

Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial

(2011) Marijke R Wevers et al.   BMC CANCER

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians

(2011) Katrina F. Trivers et al.   CANCER

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

(2011) Douglas E Levy et al.   GENETICS IN MEDICINE

Awareness and Utilization of BRCA1/2 Testing Among U.S. Primary Care Physicians

(2010) Cecelia A. Bellcross et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer

(2010) Judy C. Boughey et al.   ANNALS OF SURGICAL ONCOLOGY

Outcomes and process in genetic counselling

(2010) Angus Clarke et al.   CLINICAL GENETICS

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation inBRCA1orBRCA2

(2010) Kathleen E. Malone et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2010) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations

(2010) Larissa A. Meyer et al.   OBSTETRICS AND GYNECOLOGY

Recall of and Reactions to a Surgeon Referral Letter for BRCA Genetic Counseling Among High-Risk Breast Cancer Patients

(2009) Susan T. Vadaparampil et al.   ANNALS OF SURGICAL ONCOLOGY

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY